Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Iridex (IRIX) EBT (2016 - 2026)

Iridex has reported EBT over the past 17 years, most recently at -$834000.0 for Q1 2026.

  • Quarterly results put EBT at -$834000.0 for Q1 2026, down 110.64% from a year ago — trailing twelve months through Jan 2026 was -$5.0 million (down 2998.16% YoY), and the annual figure for FY2026 was -$5.0 million, down 2998.16%.
  • EBT for Q1 2026 was -$834000.0 at Iridex, up from -$1.6 million in the prior quarter.
  • Over the last five years, EBT for IRIX hit a ceiling of $7.8 million in Q4 2024 and a floor of -$3.4 million in Q1 2024.
  • Median EBT over the past 5 years was -$1.7 million (2023), compared with a mean of -$238882.4.
  • Peak annual rise in EBT hit 614.6% in 2022, while the deepest fall reached 258.74% in 2022.
  • Iridex's EBT stood at $6.4 million in 2022, then rose by 5.66% to $6.8 million in 2023, then rose by 15.74% to $7.8 million in 2024, then tumbled by 120.02% to -$1.6 million in 2025, then skyrocketed by 46.85% to -$834000.0 in 2026.
  • The last three reported values for EBT were -$834000.0 (Q1 2026), -$1.6 million (Q3 2025), and -$973000.0 (Q2 2025) per Business Quant data.